Evidence map›Paper›PMID 12713442›Full record

ArticleThe Biochemical journal2003

Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells.

Edward McKenzie, Kathryn Young, Margaret Hircock, James Bennett, Maina Bhaman, Robert Felix, Paul Turner, Alasdair Stamps, David McMillan, Giles Saville and 10 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in The Biochemical journal, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 115 citations in OpenAlex.

  1. Review
  2. Review
  3. Forty Years of Basic and Translational Heparanase Research.Advances in experimental medicine and biology · 2020
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Overexpression of heparanase is associated with preeclampsia by inhibiting invasion of trophocytes.International journal of clinical and experimental medicine · 2015
    Article
  10. Article
  11. Article
  12. Versatile role of heparanase in inflammation.Matrix biology : journal of the International Society for Matrix Biology · 2013
    Review
  13. Involvement of heparanase in atherosclerosis and other vessel wall pathologies.Matrix biology : journal of the International Society for Matrix Biology · 2013
    Review
  14. Review
  15. Article
  16. Heparanase enzyme in chronic inflammatory bowel disease and colon cancer.Cellular and molecular life sciences : CMLS · 2012
    Review
  17. Significance of heparanase in cancer and inflammation.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2012
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 2 countries.

Edward McKenzieOxford GlycoSciences (OGS), 10 The Quadrant, Abingdon Science Park, Abingdon, Oxon OX14 3YS, UK.
Kathryn Young
Margaret Hircock
James Bennett
Maina Bhaman
Robert Felix
Paul Turner
Alasdair Stamps
David McMillan
Giles Saville
Stanley Ng
Sean Mason
Daniel Snell
Darren Schofield
Haiping Gong
Reid Townsend
John Gallagher
Martin Page
Raj Parekh
Colin Stubberfield
Oxford Lasers (United Kingdom) · GBCancer Research UK Manchester Institute · GBVion Pharmaceuticals (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mammalian endoglycosidase heparanase (Hpa1) is primarily responsible for cleaving heparan sulphate proteoglycans (HSPGs) present on the basement membrane of cells and its potential for remodelling the extracellular matrix (ECM) could be important in embryonic development and tumour metastasis. Elevated expression of this enzyme has been implicated in various pathological processes including tumour cell proliferation, metastasis, inflammation and angiogenesis. The enzyme therefore represents a potential therapeutic target. Hpa1 protein is initially synthesized as an inactive 65 kDa proenzyme that is then believed to be subsequently activated by proteolytic cleavage to generate an active heterodimer of 8 and 50 kDa polypeptides. By analysis of a series of Hpa1 deletion proteins we confirm that the 8 kDa subunit is essential for enzyme activity. We present here for the first time an insect cell expression system used for the generation of large amounts of recombinant protein of high specific activity. Individual subunits were cloned into baculoviral secretory vectors and co-expressed in insect cells. Active secreted heterodimer protein was recovered from the medium and isolated by a one-step heparin-Sepharose chromatography procedure to give protein of >90% purity. The recombinant enzyme behaved similarly to the native protein with respect to the size of HS fragments liberated on digestion, substrate cleavage specificity and its preference for acidic pH. A significant amount of activity, however, was also detectable at physiological pH values, as measured both by an in vitro assay and by in vivo degradation of cell-bound heparan sulphate.

Indexed as

Gene Expression Regulation, EnzymologicAmidohydrolasesAnimalsBaculoviridaeBlood PlateletsChromatography, AffinityDimerizationFibrinolytic AgentsGenetic VectorsGlucuronidaseHeparanaseHeparan SulfateHeparinHumansImmunoenzyme TechniquesMass SpectrometryAmidohydrolasesFibrinolytic AgentsGlucuronidaseHeparanaseHeparan SulfateHeparinPeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseRecombinant Proteins

Identifiers

PMID12713442
PMCPMC1223510
OpenAlexW2043451019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.